Patients receiving anti-GM-CSF antibodies are theoretically at increased risk of aPAP8, and administration of GM-CSF-autoantibodies from a pulmonary alveolar proteinosis patient has been shown to induce pathologic manifestations of pulmonary alveolar proteinosis in healthy macaques30. This evidence concerns the gene CSF2 and pulmonary alveolar proteinosis.